Selecting Methodologies for the Evaluation of Differences in Time to Response Between Antidepressants.[CME]
J Clin Psychiatry 2002;63(8):694-699
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: The delay in the
therapeutic effect of antidepressants is a considerable
impediment to their successful clinical use, and
attention has recently been focused on antidepressant
drugs that may have a faster onset of action.
Data Synthesis: Several methodologies
exist for evaluating differences in time to response
between antidepressants including the
identification of the timepoint at which statistically or
clinically significant differences between treatment
groups emerge, pattern analysis, and survival
analytical approaches. All have conceptual as well as
practical advantages and disadvantages.
Conclusion: The survival analytical
approach is generally considered to be the most
rigorous and sensitive in detecting differences in the
speed of response of antidepressants, but the
other methodologies provide useful information.